The global market for foam dressings  is expected to grow at a significant CAGR during the forecast period (2021-2027). Foam dressings are made of semipermeable polyurethane and are used to treat wounds. They are non-adherent, non-linting dressings that only allow water vapor to pass through, preventing germs and other pollutants from entering.

Foam dressings have broadened the toolkits availability to physicians looking for better dressings for a variety of wounds. They have been increasingly popular in recent years as a result of their primary benefit of creating a moist environment that promotes quicker wound healing. They are nonadherent and nonlinting in nature. Foam dressings provide a number of advantages, including periwound protection and ease of supply, which has kept the market growing. Foam dressings have therefore become the preferred dressings for a range of wound types in patient population all over the globe.

A significant factor driving the global demand for foam dressings is the growing need for inexpensive treatment for patients with chronic and acute wounds in diverse care settings. The growing prevalence of pressure injuries in patients of all ages in various areas of the globe is expected to drive the global foam dressings market. Foam dressings are used to treat pressure ulcers which shows their high potential in bed sores. Several studies have been conducted by NCBI in recent years to determine the therapeutic relevance and cost-effectiveness of foam dressings in the treatment of pressure injuries. The rising morbidity of lifestyle illnesses such as diabetes is driving up the demand for foam dressings to help with wound healing. Several training programmes devised by various institutes such as Helogics and Wound Educators, among others, have been developed in recent years to improve the methods of wound treatment dressings. This encourages people to use foam dressings. 

To combat the adverse effects of systemically administered analgesics, a new therapeutic class of local pain-relieving dressings was created, combining moisture-balancing foam dressings with the release of low-dose nonsteroidal anti-inflammatory medications (NSAIDs), such as ibuprofen.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Type – Foam Dressings With Adhesive Border, Foam Dressings With Silicone Border

o By Pore Size – Small Pore Size Foam Dressings, Medium Pore Size Foam Dressings, Large Pore Size Foam Dressings

o By End – User – Hospitals, Clinics, Homecare

    • Competitive Landscape:  3M Company, Johnson & Johnson, Medtronic Plc., Mlnlycke Health Care AB, Cardinal Health, Medline Industries, Inc., Smith & Nephew Plc., Winner Medical Group Inc., Smith & Nephew plc, and BSN Medical.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Foam Dressings Market Report 

By Type

    • Foam Dressings with Adhesive Border

    • Foam Dressings with Silicone Border

By Pore Size

    • Small Pore Size Foam Dressings

    • Medium Pore Size Foam Dressings

    • Large Pore Size Foam Dressings

By End – User

    • Hospitals

    • Clinics

    • Homecare

By Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa